Changes in Beneficial Ownership · 4
Bicara Therapeutics Inc.
BCAXNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1786740871.xml
Filing details
- Report period
- 2026-08-12
- Issuer
- Bicara Therapeutics Inc.
- Issuer CIK
- 0002023658
- Trading symbol
- BCAX
Reporting owner 1
- Name
- Larson Jennifer
- Reporting owner CIK
- 0002149587
- Relationship
- Officer
- Officer title
- Chief Financial Officer
- Address
- BICARA THERAPEUTICS INC., 116 HUNTINGTON AVENUE, SUITE 703, BOSTON, MA, 02116
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | 24.63 | 2026-08-12 | A · Form 4 | 285,000 | A | 0 | [F1] | 2036-08-12 | Common Stock | 285,000 | 285,000 | D |
Table key
- A · Form 4
- Acquisition by grant, award or otherwise under Rule 16b-3(d)
- A
- Acquired
- D
- Direct
Footnotes
- F1
- 25% of the shares subject to this option vest and become exercisable on August 12, 2027, with the remainder vesting in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.↩ 1
Signature 1
- Signed
- /s/ Ryan Cohlhepp, Attorney-in-Fact
- Date
- 2026-08-14
Recent company filings
- SCHEDULE 13G/A - filed by T. Rowe Price Investment Management, Inc. regarding Bicara Therapeutics Inc.Oct 7, 2026
- Entry into a Material Definitive AgreementAug 25, 2026
- SCHEDULE 13G/A - filed by Janus Henderson Group Ltd. regarding Bicara Therapeutics Inc.Aug 13, 2026
- S-8 filingAug 11, 2026
- 10-Q filingAug 11, 2026